medigraphic.com
ISSN 1665-3254 (Print)
Revista Oficial de la Universidad Biomédica Rafael Guízar y Valencia A. C.

2005, Number 1-2

<< Back Next >>

Plasticidad y Restauración Neurológica 2005; 4 (1-2)

Diabetic neuropathy. Practical aspects for the first contact medical doctor’s

Aguilar-Rebolledo F

Language: Spanish
References: 32
Page: 35-47
PDF size: 178.75 Kb.


Text Extraction

No Abstract


REFERENCES

  1. Petit WA Jr, Upender RP. Medical evaluation and treatment of diabetic peripheral neuropathy. Clin Podiatr Med Surg 2003;20:655-69.

  2. Harati Y. Diabetes and the nervous system. In: Chronic complications of diabetes. Endocrinol Metab Clin N 1996;25(2):325-31.

  3. Jakobsen J. Diabetic Neuropathy. Curr Opin Neurol 1994;7:381-84.

  4. Klein R. Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Annals Int Med 1996;124(1):90-95.

  5. Nathan DM. The pathophysiology of diabetic complications: how much does the glucose hypothesis explain? Ann Int Med 1996;124(1):86-90.

  6. Feldman EL. A practical two-step qualitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994;170(1): 1281-86.

  7. Max ME. Effects of desipramine, amitriptyline and fluoxetine on pain in diabetic neuropathy. NEJM 1992;326(9):1250.

  8. Greene DA. Sorbitol, phosphoinositides and sodium-potasium-ATPase in the pathogenesis of diabetic complications. NEJM 1987;3)6(10):599-604.

  9. Lohmann M, Thomsen JK, Edmonds ME, Harding KG, Apelqvist J, Gottrup F. Safety and performance of a new non-adhesive foam dressing for the treatment of diabetic foot ulcers. J Wound Care 2004;13(3): 118-20.

  10. Solagberu BA. Diabetic foot in Nigeria—a review article. Afr J Med Sci 2003;32(2):111-16.

  11. Jones J, Gorman A. Evaluation of the impact of an educational initiative in diabetic foot management. Br J Community Nurs 2004;9(3):S20-6.

  12. Nardone A, Schieppati M. Group II spindle fibres and afferent control of stance. Clues from diabetic neuropathy. J Investig Med 2004;52(1):33-44.

  13. Cowell RM, Russell JW. Nitrosative injury and antioxidant therapy in the management of diabetic neuropathy. Clin Neurophysiol 2004;115(4):779-89.

  14. Berger A, Dukes EM, Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain 2004;5(3):143-9.

  15. Erewster WJ. Diabetic neuropathy, nerve growth factor and other neurotrophic factors. TINS 1994;7(8):321-24.

  16. Anand P. Neurotrophic factors and their receptors in human sensory neuropathies. Prog Brain Res 2004;146: 477-92.

  17. Pittenger G, Vinik A. Nerve growth factor and diabetic neuropathy. Exp Diabetic Res 2003;4(4):271-85.

  18. Leinninger GM, Vincent AM, Feldman EL. The role of growth factors in diabetic peripheral neuropathy. J Peripher Nerv Syst 2004;9(1):26-53.

  19. Schweitzer ME, Morrison WB. MR imaging of the diabetic foot. Radiol Clin North Am 2004;42(1):61-71.

  20. Siemionow M, Demir Y. Diabetic neuropathy: pathogenesis and treatment. J Reconstr Microsurg 2004;20(3):241-52.

  21. Luft D. Interpretation of clinical trials for the treatment of diabetic neuropathy. Drugs Today (Barc) 1998;34(2):157-75.

  22. Trotta D, Verrotti A, Salladini C, Chiarelli F. Diabetic neuropathy in children and adolescents. Pediatric Diabetes 2004;5(1):44-57.

  23. Newton WP, Collins L, Fotinos C. What is the best treatment for diabetic neuropathy? Fam Pract 2004;53(5):403-8.

  24. Younger DS. Diabetic peripheral neuropathy. Drugs Today (Barc) 1998;34(8):699-708.

  25. Russo A, Botten R, Kong MF, Chapman IM, Fraser RJ, Horowitz M, Sun WM. Effects of acute hyperglycaemia on anorectal motor and sensory function in diabetes mellitus. Diabet Med 2004;21(2):176-82.

  26. Brunelli B, Gorson KC. The use of complementary and alternative medicines by patients with peripheral neuropathy. J Neurol Sci 2004;218(1-2):59-66.

  27. Duby JJ, Campbell RK, Setter SM, White JR, Rasmussen KA. Diabetic neuropathy: an intensive review. Am J Health Syst Pharm 2004;61(2):160-73.

  28. Petit WA Jr, Upender RP. Medical evaluation and treatment of diabetic peripheral neuropathy. Clin Podiatr Med Surg 2003:20(4):671-88.

  29. Mack A. Examination of the evidence for off-label use of gabapentin. J Manag Care Pharm 2003;9(6):559-68.

  30. Beydoun A, Kobetz SA, Carrazana EJ. Efficacy of oxcarbazepine in the treatment of painful diabetic neuropathy. Clin J Pain 2004;20(3):174-8.

  31. Niinikoski J. Hyperbaric oxygen therapy of diabetic foot ulcers, transcutaneous oxymetry in clinical decision making. Wound Repair Regen 2003;11(6):458-61.

  32. Musaev AV, Guseinova SG, Imamverdieva SS. The use of pulsed electromagnetic fields with complex modulation in the treatment of patients with diabetic polyneuropathy. Neurosci Behav Physiol 2003;33(8):745-52.




2020     |     www.medigraphic.com